Clinical trial
Study of Imatinib-Combined Chemotherapy for BCR-ABL-Positive Acute Lymphoblastic…
NCT00130195 · Japan Adult Leukemia Study Group, Other · Completed
Key facts
| NCT number | NCT00130195 |
|---|---|
| Title | Study of Imatinib-Combined Chemotherapy for BCR-ABL-Positive Acute Lymphoblastic Leukemia (ALL) |
| Official title | Phase 2 Study of Imatinib-Combined Chemotherapy for Newly Diagnosed BCR-ABL-Positive Acute Lymphoblastic Leukemia |
| Lead sponsor | Japan Adult Leukemia Study Group, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Acute Lymphoblastic Leukemia |
| Intervention type | Drug |
| Interventions | imatinib, cyclophosphamide, daunorubicin, vincristine, prednisolone, methotrexate, cytarabine, dexamethasone |
| Enrollment | 100 |
| Start date | Sep 1, 2002 |
| Primary completion | Feb 1, 2008 |
| Completion | May 1, 2008 |
| First posted | Aug 15, 2005 |
| Last update posted | Nov 14, 2008 |
| Countries | Japan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: